The most significant adverse events from GLP-1 agonists include gastrointestinal side effects such as nausea and vomiting secondary to impaired gastric emptying
However, these studies also provide valuable insights into its side effects, including its impact on the gastrointestinal system
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Though currently only FDA-approved for type 2 diabetes and obesity, people who have type 1 diabetes may want to take GLP-1 agonists for benefits besides just shedding unwanted pounds
Or they've eaten dinner, and the next morning they don't feel like eating breakfast because they still feel full from the meal the night before. How Is Gastroparesis Diagnosed
Smoothie Kings GLP-1 Support Menu includes five smoothies that were created to support some of the most common challenges people experience on GLP-1 medications